Aisling Capital collects over $144m for fifth fund

Aisling Capital has raised over $144 million for its fifth fund, according to an SEC filing.

Aisling Capital has raised over $144 million for its fifth fund, according to an SEC filing. No target was listed in the document. Based in New York City, the life science investment firm invests in companies that are developing healthcare products.

Source: SEC filing